Tweed will be able to access all the data from BED's ongoing 8 clinical trials, and 20 completed clinical trials. BED was investigating oils/extracts in Europe years ago, and have many R&D projects on the side regarding precise dosage THC inhalers that can only work with BED product as they are the only one that can gaurantee a consistant THC/CBD dosage per single bud.
What Tweed needs to do inhouse testing is the HC "Dealers" licence to be approved so they can begin extracting with the 9 months of trimmings they have saved. They are first in line and front of the queue for this.
Market Data 
Markets 
AI
